Side Effects of Ranibizumab

The most commonly reported side effects of ranibizumab include redness or blood spots on the whites of the eyes, specks in your vision, and eye pain. Although these side effects are generally minor and don't require treatment, it is possible to develop serious ranibizumab side effects. Notify your healthcare provider right away if you experience eye infections, decreased vision, or blood clots during treatment.

 

An Introduction to Side Effects of Ranibizumab

As with any medicine, side effects are possible with ranibizumab (Lucentis®); however, not everyone who takes the drug will experience side effects. In fact, most people tolerate it quite well. If side effects do occur, in most cases, they are minor and either require no treatment or can easily be treated by you or your healthcare provider.
 
(This article covers many, but not all, of the possible side effects with ranibizumab. Your healthcare provider can discuss a more complete list of ranibizumab side effects with you.)
 

Common Side Effects of Ranibizumab

Ranibizumab has been studied thoroughly in clinical trials. In these studies, the side effects that occur in a group of people taking the drug are documented and are then compared to side effects that occur in another group of people not taking the medicine. This way, it is possible to see what side effects occur, how often they appear, and how they compare to the group not taking the medicine.
 
In these studies, the most common side effects of ranibizumab included:
 
  • Redness or blood spots on the white part of the eye -- in up to 77 percent of people
  • Eye pain -- up to 37 percent
  • Specks in your vision -- up to 32 percent
  • High blood pressure (hypertension) -- up to 23 percent
  • Feeling like there is something in your eye -- up to 19 percent
  • Eye irritation -- up to 18 percent.
     
Other common ranibizumab side effects, occurring in 4 to 17 percent of people, included:
 
(Side Effects of Ranibizumab Continued: Page 2)
Written by/reviewed by: Kristi Monson, PharmD; Arthur Schoenstadt, MD
Last reviewed by: Kristi Monson, PharmD;